Surrogate markers used as efficacy endpoints in NIH-sponsored clinical trials.
Researchers
Ayman Mohammad, Samuel Yoon, Joshua D Wallach, Reshma Ramachandran, Joseph S Ross
Abstract
No abstract available for this article.Source: PubMed (PMID: 41995414)View Original on PubMed